Abbott has reached two milestones in a pair of trials evaluating the company’s pulsed field ablation (PFA) technology for the ...
Boston Scientific, Medtronic and J&J are moving quickly to secure their place in the fast-growing pulsed field ablation space ...
Abbott has taken a step forward in the development of a new addition to its structural heart portfolio, completing the first ...
CEO Geoff Martha said the business did not meet internal growth expectations last quarter due to third-party supply issues ...
The Sphere-360 catheter was designed to simplify the ... study designed to evaluate the safety and effectiveness of Abbott's Volt PFA System. Boston Scientific too in January 2024, received ...
Affera combines mapping technology with a catheter capable of performing ... the electrophysiology market. So far, Abbott has identified the launches of PFA devices by rivals as a factor that ...